Madrigal Pharmaceuticals
MDGL
MDGL
80 hedge funds and large institutions have $212M invested in Madrigal Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
20% less capital invested
Capital invested by funds: $266M → $212M (-$53.6M)
42% less call options, than puts
Call options by funds: $1.88M | Put options by funds: $3.23M
Holders
80
Holding in Top 10
1
Calls
$1.88M
Puts
$3.23M
Top Buyers
| 1 | +$2.55M | |
| 2 | +$712K | |
| 3 | +$680K | |
| 4 |
IIM
Ironwood Investment Management
Boston,
Massachusetts
|
+$522K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$514K |
Top Sellers
| 1 | -$9.22M | |
| 2 | -$1.79M | |
| 3 | -$1.26M | |
| 4 |
Renaissance Technologies
New York
|
-$1.12M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$708K |